BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24554540)

  • 21. Porphyromonas gingivalis infection enhances Th17 responses for development of atherosclerosis.
    Cai Y; Kobayashi R; Hashizume-Takizawa T; Kurita-Ochiai T
    Arch Oral Biol; 2014 Nov; 59(11):1183-91. PubMed ID: 25103543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic dependence of the specific T-cell cytokine response to Porphyromonas gingivalis in mice.
    Gemmell E; Carter CL; Bird PS; Seymour GJ
    J Periodontol; 2002 Jun; 73(6):591-6. PubMed ID: 12083530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porphyromonas gingivalis heat shock protein vaccine reduces the alveolar bone loss induced by multiple periodontopathogenic bacteria.
    Lee JY; Yi NN; Kim US; Choi JS; Kim SJ; Choi JI
    J Periodontal Res; 2006 Feb; 41(1):10-4. PubMed ID: 16409250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation in the recognition of Porphyromonas gingivalis antigens in mice.
    Gemmell E; Sernia C; Grieco DA; Bird PS; Allen CJ; Seymour GJ
    Oral Microbiol Immunol; 2001 Jun; 16(3):129-35. PubMed ID: 11358534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell clonality to Porphyromonas gingivalis and human heat shock protein 60s in patients with atherosclerosis and periodontitis.
    Yamazaki K; Ohsawa Y; Itoh H; Ueki K; Tabeta K; Oda T; Nakajima T; Yoshie H; Saito S; Oguma F; Kodama M; Aizawa Y; Seymour GJ
    Oral Microbiol Immunol; 2004 Jun; 19(3):160-7. PubMed ID: 15107067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage.
    Foteinos G; Afzal AR; Mandal K; Jahangiri M; Xu Q
    Circulation; 2005 Aug; 112(8):1206-13. PubMed ID: 16116071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of regulatory T cells in atheroprotective effects of granulocyte colony-stimulating factor.
    Uchiyama R; Hasegawa H; Kameda Y; Ueda K; Kobayashi Y; Komuro I; Takano H
    J Mol Cell Cardiol; 2012 May; 52(5):1038-47. PubMed ID: 22285481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.
    Kimura T; Tse K; McArdle S; Gerhardt T; Miller J; Mikulski Z; Sidney J; Sette A; Wolf D; Ley K
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H781-H790. PubMed ID: 28087520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusobacterium nucleatum GroEL induces risk factors of atherosclerosis in human microvascular endothelial cells and ApoE(-/-) mice.
    Lee HR; Jun HK; Kim HD; Lee SH; Choi BK
    Mol Oral Microbiol; 2012 Apr; 27(2):109-23. PubMed ID: 22394469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal immunization with different forms of heat shock protein-65 reduced high-cholesterol-diet-driven rabbit atherosclerosis.
    Long J; Lin J; Yang X; Yuan D; Wu J; Li T; Cao R; Liu J
    Int Immunopharmacol; 2012 May; 13(1):82-7. PubMed ID: 22465386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of CD4+ cells in vivo on the induction of the immune response to Porphyromonas gingivalis in mice.
    Sosroseno W; Bird PS; Gemmell E; Seymour GJ
    J Periodontol; 2002 Oct; 73(10):1133-40. PubMed ID: 12416770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.
    Mor A; Planer D; Luboshits G; Afek A; Metzger S; Chajek-Shaul T; Keren G; George J
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):893-900. PubMed ID: 17272749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral infection with Porphyromonas gingivalis and systemic cytokine profile in C57BL/6.KOR-ApoE shl mice.
    Miyauchi S; Maekawa T; Aoki Y; Miyazawa H; Tabeta K; Nakajima T; Yamazaki K
    J Periodontal Res; 2012 Jun; 47(3):402-8. PubMed ID: 22097957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria.
    Noll A; Bücheler N; Bohn E; Schirmbeck R; Reimann J; Autenrieth IB
    Eur J Immunol; 1999 Mar; 29(3):986-96. PubMed ID: 10092103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.
    Chitradevi ST; Kaur G; Uppalapati S; Yadav A; Singh D; Bansal A
    Cell Mol Immunol; 2015 Nov; 12(6):757-67. PubMed ID: 25640657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
    Heller EA; Liu E; Tager AM; Yuan Q; Lin AY; Ahluwalia N; Jones K; Koehn SL; Lok VM; Aikawa E; Moore KJ; Luster AD; Gerszten RE
    Circulation; 2006 May; 113(19):2301-12. PubMed ID: 16682613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope mapping of Porphyromonas gingivalis heat-shock protein and human heat-shock protein in human atherosclerosis.
    Choi JI; Chung SW; Kang HS; Rhim BY; Park YM; Kim US; Kim SJ
    J Dent Res; 2004 Dec; 83(12):936-40. PubMed ID: 15557401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis.
    Cai Y; Kurita-Ochiai T; Hashizume T; Yamamoto M
    Pathog Dis; 2013 Feb; 67(1):76-83. PubMed ID: 23620122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
    Chi H; Messas E; Levine RA; Graves DT; Amar S
    Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.